Germany · Delayed Price · Currency is EUR Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of EUR 97.87 billion. The enterprise value is 105.07 billion.
| Market Cap | 97.87B |
| Enterprise Value | 105.07B |
Important Dates
The last earnings date was Thursday, July 31, 2025.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.95% |
| Shares Change (QoQ) | -1.36% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 10.72 and the forward PE ratio is 9.83.
| PE Ratio | 10.72 |
| Forward PE | 9.83 |
| PS Ratio | 2.14 |
| PB Ratio | 1.39 |
| P/TBV Ratio | 10.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 11.51 |
| EV / Sales | 2.30 |
| EV / EBITDA | 8.26 |
| EV / EBIT | 10.54 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.27 |
| Quick Ratio | 0.54 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.78 |
| Debt / FCF | n/a |
| Interest Coverage | 23.40 |
Financial Efficiency
Return on equity (ROE) is 9.00% and return on invested capital (ROIC) is 6.47%.
| Return on Equity (ROE) | 9.00% |
| Return on Assets (ROA) | 4.81% |
| Return on Invested Capital (ROIC) | 6.47% |
| Return on Capital Employed (ROCE) | 10.23% |
| Revenue Per Employee | 551,871 |
| Profits Per Employee | 110,114 |
| Employee Count | 82,878 |
| Asset Turnover | 0.36 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Sanofi has paid 1.54 billion in taxes.
| Income Tax | 1.54B |
| Effective Tax Rate | 19.24% |
Stock Price Statistics
The stock price has decreased by -15.68% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -15.68% |
| 50-Day Moving Average | 42.16 |
| 200-Day Moving Average | 46.84 |
| Relative Strength Index (RSI) | 35.98 |
| Average Volume (20 Days) | 75 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of EUR 45.74 billion and earned 9.13 billion in profits. Earnings per share was 7.35.
| Revenue | 45.74B |
| Gross Profit | 32.63B |
| Operating Income | 9.81B |
| Pretax Income | 7.99B |
| Net Income | 9.13B |
| EBITDA | 12.23B |
| EBIT | 9.81B |
| Earnings Per Share (EPS) | 7.35 |
Balance Sheet
The company has 15.36 billion in cash and 22.29 billion in debt, giving a net cash position of -6.93 billion.
| Cash & Cash Equivalents | 15.36B |
| Total Debt | 22.29B |
| Net Cash | -6.93B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 70.28B |
| Book Value Per Share | 57.52 |
| Working Capital | 7.96B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 71.34%, with operating and profit margins of 21.44% and 19.95%.
| Gross Margin | 71.34% |
| Operating Margin | 21.44% |
| Pretax Margin | 17.46% |
| Profit Margin | 19.95% |
| EBITDA Margin | 26.75% |
| EBIT Margin | 21.44% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.42, which amounts to a dividend yield of 3.34%.
| Dividend Per Share | 1.42 |
| Dividend Yield | 3.34% |
| Dividend Growth (YoY) | 3.06% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.95% |
| Shareholder Yield | 4.29% |
| Earnings Yield | 9.32% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |